These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26148707)

  • 21. Precision medicine and pharmacogenetics: what does oncology have that addiction medicine does not?
    Kranzler HR; Smith RV; Schnoll R; Moustafa A; Greenstreet-Akman E
    Addiction; 2017 Dec; 112(12):2086-2094. PubMed ID: 28431457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Quantitative Paradigm for Decision-Making in Precision Oncology.
    Engelhardt D; Michor F
    Trends Cancer; 2021 Apr; 7(4):293-300. PubMed ID: 33637444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment.
    Schmidt KT; Chau CH; Price DK; Figg WD
    J Clin Pharmacol; 2016 Dec; 56(12):1484-1499. PubMed ID: 27197880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. OncoPDSS: an evidence-based clinical decision support system for oncology pharmacotherapy at the individual level.
    Xu Q; Zhai JC; Huo CQ; Li Y; Dong XJ; Li DF; Huang RD; Shen C; Chang YJ; Zeng XL; Meng FL; Yang F; Zhang WL; Zhang SN; Zhou YM; Zhang Z
    BMC Cancer; 2020 Aug; 20(1):740. PubMed ID: 32770988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT).
    Mateo J; Chakravarty D; Dienstmann R; Jezdic S; Gonzalez-Perez A; Lopez-Bigas N; Ng CKY; Bedard PL; Tortora G; Douillard JY; Van Allen EM; Schultz N; Swanton C; André F; Pusztai L
    Ann Oncol; 2018 Sep; 29(9):1895-1902. PubMed ID: 30137196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Universal Genomic Testing: The next step in oncological decision-making or a dead end street?
    Holch JW; Metzeler KH; Jung A; Riedmann K; Jost PJ; Weichert W; Kirchner T; Heinemann V; Westphalen CB
    Eur J Cancer; 2017 Sep; 82():72-79. PubMed ID: 28648701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An appraisal of drug development timelines in the Era of precision oncology.
    Jardim DL; Schwaederle M; Hong DS; Kurzrock R
    Oncotarget; 2016 Aug; 7(33):53037-53046. PubMed ID: 27419632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical models for precision oncology.
    Ibarrola-Villava M; Cervantes A; Bardelli A
    Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):239-246. PubMed ID: 29959990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Tumor Boards: Realizing Precision Oncology Therapy.
    Patel M; Kato SM; Kurzrock R
    Clin Pharmacol Ther; 2018 Feb; 103(2):206-209. PubMed ID: 29134641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolution of precision oncology-guided treatment paradigms.
    DasGupta R; Yap A; Yaqing EY; Chia S
    WIREs Mech Dis; 2023 Jan; 15(1):e1585. PubMed ID: 36168283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enabling Precision Oncology Through Precision Diagnostics.
    Brown NA; Elenitoba-Johnson KSJ
    Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The breakthrough of personalized medicine, new hopes and new challenges].
    Flippot R; Massard C; Auclin E; Azria D; Bourien H; Rochigneux P; Schernberg A; Verlingue L; Zafrani L; Vignot S
    Bull Cancer; 2017 Sep; 104(9):735-743. PubMed ID: 28807365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated patient and tumor genetic testing for individualized cancer therapy.
    Hertz DL; McLeod HL
    Clin Pharmacol Ther; 2016 Feb; 99(2):143-6. PubMed ID: 26537014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perspective on Precision Medicine in Oncology.
    Johnson TM
    Pharmacotherapy; 2017 Sep; 37(9):988-989. PubMed ID: 28632968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. American Society of Clinical Oncology Developing First Clinical Trial.
    Brower V
    J Natl Cancer Inst; 2015 Nov; 107(11):djv356. PubMed ID: 26538625
    [No Abstract]   [Full Text] [Related]  

  • 36. Current-day precision oncology: from cancer prevention, screening, drug development, and treatment - have we fallen short of the promise?
    Morgan G; Aftimos P; Awada A
    Curr Opin Oncol; 2016 Sep; 28(5):441-6. PubMed ID: 27428363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference.
    Hall WA; Bergom C; Thompson RF; Baschnagel AM; Vijayakumar S; Willers H; Li XA; Schultz CJ; Wilson GD; West CML; Capala J; Coleman CN; Torres-Roca JF; Weidhaas J; Feng FY
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):274-284. PubMed ID: 28964588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of the CNS TAP tool for the selection of precision medicine therapies in neuro-oncology.
    Linzey JR; Marini BL; Pasternak A; Smith C; Miklja Z; Zhao L; Kumar-Sinha C; Paul A; Harris N; Robertson PL; Hoffman LM; Chinnaiyan A; Mody R; Koschmann C
    J Neurooncol; 2018 Mar; 137(1):155-169. PubMed ID: 29235051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Trials in the Evolving Landscape of Precision Medicine.
    Cancer Cell; 2020 Jul; 38(1):3-8. PubMed ID: 32663468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Building a personalized medicine infrastructure at a major cancer center.
    Meric-Bernstam F; Farhangfar C; Mendelsohn J; Mills GB
    J Clin Oncol; 2013 May; 31(15):1849-57. PubMed ID: 23589548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.